28-02-2026 05:56 Home | Feedback | Sitemap| Careers | Contact Us |FAQ | Investor Complaints Data | Investor Charter Stock-Broker | Investor DP
  You Are On: EQUITY
Equity Analysis
Price
Gainers & Losers
Out & Under Performers
Only Buyers & Sellers
Advances & Declines
New Highs & Lows
Weightage
5 Day's Up & Down
Historical Returns
Volume
Analysis
News Analysis
Corporate Action
Corporate Info
Other Market
Share Holdings
Mankind Pharma Ltd.
 
BSE Code 543904
ISIN Demat INE634S01028
Book Value 386.62
NSE Code MANKIND
Dividend Yield % 0.00
Market Cap 927841.32
P/E 54.46
EPS 41.27
Face Value 1  
Description ( As On December 2025 )No. of ShareHoldersNo. of Shares% of SharesDemat
Promoter          
  Indian Promoter  13  299960612  72.66  299960612  
  Foreign Promoter          
  Total Promoter  13  299960612  72.66  299960612  
          
Non Promoter          
 Institutions          
  Mutual Funds / UTI  31  38389473  9.3  38389473  
  FI/Bank/Insurance  14  4606066  1.12    
  Govt          
  FII          
  Other  528  58336415  14.13  58336415  
  Total Institutions  573  101331954  24.55  101331954  
 Non-Institution          
  Bodies Corporate  631  4452177  1.08  4452177  
  Individuals          
  NRIs/OCBs  2583  241511  0.06  241511  
  Others  173739  6818818  1.65  6818818  
  Total Non-Institution  176953  11512506  2.79  11512506  
Total Non Promoter  177526  112844460  27.34  112844460  
          
  Depository Receipts          
          
Grand Total  177539  412805072  100  412805072  
 

Attention Investors : Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers / DP and Exchanges / Depository. Receive information of your transactions directly from Exchanges / Depository on your mobile/email at the end of the day .......... Issued in the interest of investors

KYC is one time exercise while dealing in securities markets – once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

“No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application from to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account.’

Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.